Background: Cardiovascular complications are common in type 1 diabetes mellitus and there is an increased risk of bradyarrhythmias as a result of dysfunction of the cardiac conduction system. We have shown that, in vivo, there is a decrease in the heart rate in streptozotocin-induced diabetic rats (266 ± 13 versus 316 ± 11 beats/min; P